In case you missed it: The innovation community and Amgen employees across the Puget Sound region have been working through the implications of the planned 2015 closure of the Seattle and Bellevue offices. Amidst creative speculation over the use of the company’s beautiful Seattle offices, we wanted to chime in with some thoughts for this incredibly talented workforce.
As you and your families navigate the path ahead in the coming months, we wanted to take a moment to note just some of the ways you’ve helped put Seattle on the global map of innovation.
- The Emerald City has been recognized as one of the top five largest life sciences clusters in the country, in no small part due to your work and that of your former Immunex colleagues.
- In the first half of 2014, 2/3 of the investment dollars ($300M) and 1/4 (or 8) of the deals were in the Life Sciences sector. The trend continues upward; already in 2014 Life Sciences investments are 40% above the total for 2013.
- Arch Ventures just oversubscribed their $400M fund,and is bullish on our region’s prospects in biotechnology.
- This industry attracts investment capital from across the country, and the world; this visibility is part of your ongoing legacy.
In your decision-making process, please remember that we’re from the government (well, some of us), and we’re here to help (all the below). Check out these resources if you haven’t already:
- The WBBA
- The Economic Development Council of Seattle and King County: Life Sciences and Healthcare
- Washington State: Life Sciences and Global Health
- Washington Global Health Alliance
Next, for some news you can use, of the 16 Seattle-based companies that have received recent rounds of funding, five are advertising open positions. (For details, check out this spreadsheet: life sciences funding-hiring)
Last but not least….thinking about embarking on your own entrepreneurial endeavor? The University of Washington has been ranked one of the top 15 Life Sciences universities in the world….snap up some of that talent!